Testing demonstrates an automated semi-continuous process strategy for viral inactivation with steps that mimic batch processing.
Kyle Jones
Advertisement
Kyle Jones is R&D applications scientist II at Pall Biotech.
Articles by Kyle Jones
Advertisement
Latest Updated Articles
Assessing Viral Inactivation for Continuous ProcessingPublished: September 28th 2018 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
2
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
3
Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care
4
$1.8M RedHill Deal Highlights Growing Worldwide Focus on H. pylori Treatment Access
5
